| Literature DB >> 28542635 |
Masatoshi Ooga1,2, Teruhiko Wakayama1,2.
Abstract
Chromatin looseness, which can be analyzed by fluorescence recovery after photobleaching (FRAP) using eGFP-tagged core histone proteins, is an important index of the differentiation potential of blastomere cells and embryonic stem cells. Whether chromatin looseness is a reliable index of the developmental potential of embryos during ontogenesis is not known. As a necessary first step toward answering this question, we investigated whether FRAP-analyzed embryos are capable of normal preimplantation and full-term development. All tested concentrations (50, 100, and 250 ng/μL) of microinjected eGFP-H2B mRNA were sufficient for detecting differences in chromatin looseness between male and female pronuclei. After FRAP analysis, most of the zygotes developed into blastocysts. Importantly, a considerable number of offspring developed from the FRAP analyzed zygotes (32/78; 41.0%) and grew into healthy adults. The offspring of zygotes injected with 250 ng/μL of eGFP-H2B mRNA and bleached using 110 μW laser power for 5 s were not genetically modified. Interestingly, bleaching using a 3-fold stronger laser intensity for a 6-fold longer time did not cause toxicity during preimplantation development, indicating that bleaching did not critically affect preimplantation development. Finally, we confirmed that similar results were obtained using two different types of confocal laser-scanning microscopes. This FRAP protocol would be useful for investigating the association between chromatin looseness and development.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28542635 PMCID: PMC5440048 DOI: 10.1371/journal.pone.0178255
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Optimization of fluorescence recovery after photobleaching (FRAP).
(A) mRNA encoding eGFP-H2B was injected into the cytoplasm of 1-cell-stage embryos 1 h post-insemination (hpi). The eGFP-H2B–expressing zygotes were collected at 8–12 hpi and subjected to FRAP analysis. Representative photographs of FRAP analysis were taken before bleaching (A-1), soon after bleaching (A-2), and after recovery (A-3). Regions of interests (ROIs) are indicated by red rectangles. The nuclear membranes (white dotted lines) and nucleoli (asterisks) are indicated. Scale bar = 10 μm. (B) Recovery curves obtained from zygotes injected with eGFP-H2B mRNA at 50, 100, and 250 ng/μL. Curves indicate fluorescence recovery in male (blue) and female (red) pronuclei. Three independent experiments were performed in which 31, 30, and 21 embryos were examined in total, respectively. (C) Recovery curve obtained using newer confocal laser scanning microscope (FV1200). Data shown are from three independent experiments, examining 58 embryos in total. (D, E) Recovery curves and mobile fraction obtained from zygotes prepared by using spermatozoa from ICR, BDF1, B6N, and C3H. At least three experiments were performed in which 45, 35, 27 and 31 embryos were used, respectively. Single dots indicate individual pronuclei; blue and red dots indicate the mobile fraction score obtained from each male and female pronuclei, respectively. Asterisks indicate significant differences between male and female pronuclei (P < 0.05, by paired t test) (F) Preimplantation development of FRAP-analyzed embryos with eGFP-H2B mRNA at 250 ng/μL. Representative images of FRAP-analyzed preimplantation developing embryos are shown. Two-cell, 4–8 cell, and blastocyst stage embryos at 24, 48, and 96 hpi, respectively. Yellow circle indicates the well-developed blastocyst. This blastocyst is enlarged and shown on the right panel. Scale bar = 100 μm. (G) Bar graph of developmental rates of FRAP-analyzed embryos. Bars indicate FRAP-analyzed (FRAP) embryos (black) and controls embryos (white) injected with mRNA but no FRAP analysis (No FRAP). Data shown are from three independent experiments, examining at least 57 embryos in total. Two-cell, 4–8 cell, morula (Mo), and blastocyst (Bl) stages were observed at 24, 48, 72, and 96 hpi, respectively.
Preimplantation development of the zygotes injected with mRNA at various concentrations.
| Concentration of mRNA | 1 cell (%) (12 hpi) | 2 cell (%) (24 hpi) | 4–8 cell (%) (48 hpi) | Mor. (%) (72 hpi) | Blast. (%) (96 hpi) |
|---|---|---|---|---|---|
| Intact | 72 (100) | 70 (97.2) | 66 (91.7) | 68 (94.4) | 66 (91.7) |
| 50 | 63 (100) | 63 (100) | 62 (98.4) | 61 (96.8) | 57 (90.5) |
| 100 | 70 (100) | 70 (100) | 67 (95.7) | 67 (95.7) | 63 (90.0) |
| 250 | 72 (100) | 71 (98.6) | 64 (88.9) | 64 (88.9) | 58 (80.6) |
| 500 | 71 (100) | 71 (100) | 67 (94.4) | 66 (93.0) | 59 (83.1) |
*: At 72 hpi, the embryos developed to morula stage
Birth rate of analyzed embryos.
| Categories | No. of injected zygotes | No. of recovered zygotes after mRNA injection (%) | No. of zygotes analyzed | No. of transferred 2-cell stage embryos (%) | No. of recipients | No. of pups (%) | Weight of pups (g) | No. of transgenic pups |
|---|---|---|---|---|---|---|---|---|
| Intact | - | - | 99 | 98 (99.0) | 9 | 61 (62.2)a | 1.64±0.02 | n.d |
| No FRAP | 420 | 398 (94.8) | 82 | 78 (95.1) | 7 | 41 (52.6)a, b | 1.66±0.03 | n.d |
| FRAP | 79 | 78 (98.7) | 7 | 32 (41.0)b | 1.69±0.03 | 0 |
*: calculated by dividing with no. of injected zygotes
**: calculated by dividing with no. of zygotes analyzed
***: calculated by dividing with no. of transferred 2-cell stage embryos. a,b: superscripts indicate significant difference (P<0.05). n.d: not determined
Fig 2Healthy pups derived from FRAP-analyzed zygotes.
Photographs of the pups obtained from FRAP-analyzed zygotes (A). Normal growth was observed during nursing of the FRAP-analyzed pups (B) and chart indicating the weights of pups derived from intact embryos (blue), unbleached control embryos (red), and FRAP-analyzed embryos (green). Body weights of 29 pups derived from intact embryos, 24 from no-FRAP embryos, and 15 from FRAP-analyzed embryos over an 8-week period. (D) PCR genotyping of 15 pups derived from FRAP-analyzed embryos. DNA was extracted from tails and purified for use as PCR templates. Mr, indicates molecular marker. P.C (positive control) was prepared with using a GFP-expressing transgenic ICR mouse. A mouse derived from intact zygotes was used as an N.C (negative control).
Fig 3Tolerance of zygotes to photobleaching.
(A) The effects of stronger and/or longer photobleaching on preimplantation development were investigated. Preimplantation development of the embryos subjected to 3-fold stronger (300 μW) and/or 6-fold longer (30 s) bleaching than the standard conditions (110 μW; 5 s). Confocal images of embryos during FRAP analysis. ROIs are indicated by red rectangles. Scale bar = 10 μm. The blastocysts shown on the right were derived from the FRAP-analyzed zygotes shown on the left. (Scale bar = 100 μm). (B) Rate of development of embryos subjected to standard (110 μW, 5 s) and stronger and longer (300 μW, 30 s) bleaching: unbleached control, white; standard, gray; and stronger/longer bleaching, black. Three independent experiments were performed in which at least 42 embryos were examined in total. Two-cell, 4–8 cell, morula (Mor), and blastocyst (Blast) stages were observed at 24, 48, 72, and 96 hpi, respectively. There is no significant difference between 110 μW, 5 s and 300 μW, 30 s; P value by Fisher’s exact test is P < 0.9999 (2C-Mor.) and P = 0.7136 (Blast.).